Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: A Multivariate Risk Score for Clinically Significant Cancer
L Orecchia, A Nardi, P Fletcher, S Ippoliti… - Clinical Genitourinary …, 2023 - Elsevier
Introduction Clinically significant prostate cancer (csCaP) with Gleason≥ 3+ 4 is found in
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant Cancer
L Orecchia, A Nardi, P Fletcher… - Clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Clinically significant prostate cancer (csCaP) with Gleason≥ 3+ 4 is found in
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant Cancer
L Orecchia, A Nardi, P Fletcher… - Clinical …, 2023 - clinical-genitourinary-cancer.com
Introduction Clinically significant prostate cancer (csCaP) with Gleason≥ 3+ 4 is found in
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant Cancer.
L Orecchia, A Nardi, P Fletcher, S Ippoliti… - Clinical Genitourinary …, 2022 - europepmc.org
Results At first assessment 281/469 patients had mpMRI only and 188/469 mpMRI and
biopsy, 26 csCaP were found at biopsy, including 10/26 in Likert 3 patients. 12/371 patients …
biopsy, 26 csCaP were found at biopsy, including 10/26 in Likert 3 patients. 12/371 patients …
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant Cancer.
L Orecchia, A Nardi, P Fletcher, S Ippoliti, J Grounds… - 2023 - repository.cam.ac.uk
INTRODUCTION: Clinically significant prostate cancer (csCaP) with Gleason≥ 3+ 4 is found
in 10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
in 10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
Natural History of Patients with Prostate MRI Likert 1-3 and Development of RosCaP: a Multivariate Risk Score for Clinically Significant Cancer
L Orecchia, A Nardi, P Fletcher… - Clinical …, 2023 - clinical-genitourinary-cancer.com
Introduction Clinically significant prostate cancer (csCaP) with Gleason≥ 3+ 4 is found in
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …
10% negative prebiopsy multiparametric (mp) MRI cases and varies widely for equivocal …